α-Glucosidase-IN-120
α-Glucosidase-IN-120 is an α-glucosidase (α-glucosidase) inhibitor that effectively inhibits α-glucosidase from Saccharomyces cerevisiae (IC50 = 12.01 μM, Ki = 21 μM). α-Glucosidase-IN-120 shows higher selectivity for α-glucosidase than for α-amylase and does not inhibit α-amylase activity. α-Glucosidase-IN-120 exhibits no significant cytotoxicity. α-Glucosidase-IN-120 can be used in the research of type 2 diabetes.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C35H36N4O4
- 分子量:576.68
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
IC50 & Target
[1]|
α‑glucosidase 12.01 μM (IC50) |
α‑glucosidase 21 μM (Ki) |
体外実験
α-Glucosidase-IN-120 (compound 10s) potently inhibits Saccharomyces cerevisiae α-glucosidase, with an IC50 value of 12.01 μM, which is approximately 62.5 times more potent than Acarbose (HY-B0089)[1].
α-Glucosidase-IN-120 (0-24 μM; 15 min) acts as a competitive inhibitor of Saccharomyces cerevisiae α-glucosidase, with a Ki value of 21 μM[1].
α-Glucosidase-IN-120 (100 μM; 10 min) shows no inhibitory activity against bacterial α-amylase, demonstrating high selectivity for α-glucosidase[1].
α-Glucosidase-IN-120 shows no cytotoxicity against MCF-7, HT-29, HDF and L929 cell lines at exposure for 48 h, with the maximum effective concentration reaching up to 100 μM[1].
α-Glucosidase-IN-120 induces conformational changes in α-glucosidase from *Saccharomyces cerevisiae*, increases the ordered secondary structures of α-helices and β-turns, and eliminates the native β-sheets and random coil structures[1].
α-Glucosidase-IN-120 (0-12 μM; 10 min) binds to *Saccharomyces cerevisiae* α-glucosidase with high affinity via static quenching, with a KA of 7.6 × 105 L mol-1 and approximately 1 binding site at 25 °C, and hydrophobic interaction acts as the main driving force for this interaction[1].
α-Glucosidase-IN-120 stably binds to the active site of Saccharomyces cerevisiae isomaltase, forming key hydrogen bonds and π-ion interactions associated with its potent α-glucosidase inhibitory activity[1].
α-Glucosidase-IN-120 (200 ns) forms a stable and thermodynamically favorable complex with *Saccharomyces cerevisiae* isomaltase during the 200 ns MD simulation, a result supported by persistent hydrogen bonding and hydrophobic interactions, with an average MM-GBSA binding free energy ranging from −10 to −12 kcal/mol[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
化学情報
-
分子量 576.68
-
分子式 C35H36N4O4
-
SMILES
COC1=C(OCC2=CC=C(C(NC3=CC=C(OC)C=C3)=O)C=C2)C=CC(C4=C(NC5CCCCC5)N6C=CC=CC6=N4)=C1
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
プロトコル
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Research Protocol for Metabolic Diseases
AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)